Piccolo Domenico, Fusco Irene, Zingoni Tiziano, Conforti Claudio
Novea Skin Center-Dermo Aesthetic Laser Centers, 67051 Avezzano, Italy.
El.En. Group, 50041 Calenzano, Italy.
J Clin Med. 2024 Mar 13;13(6):1646. doi: 10.3390/jcm13061646.
: Facial telangiectasias is a prevalent cosmetic disorder that can be associated with several conditions such as rosacea. IPL (intensity pulsed light) therapy is commonly used for the treatment of vascular lesions. This study tested the efficacy of an IPL system emitting selected vascular chromophore-specific wavelengths in the range of 500-1200 nm for the treatment of vascular lesions. : A total of 39 patients affected by different vascular lesions on their face were enrolled. The procedure consisted of three treatment sessions, spaced 1 month apart, using the IPL system with a 500-677 and 854-1200 nm filter. Follow-up was performed at 21-90 days (3 weeks-3 months) after the last IPL session. Three-dimensional and dermoscopic clinical photographs were captured and evaluated using a five-point scale. Adverse events were checked. : In total, 21 patients achieved excellent improvement, 13 patients achieved good improvement, 3 patients achieved moderate improvement, 2 patients achieved mild improvement, and 0 patients achieved no improvement, with an overall good response to treatment. The photographic evaluation showed good results as soon as 3 days after the last IPL session. Relevant side effects were absent. : The study device may represent a successful treatment to improve vascular lesions that are resistant to laser therapy.
面部毛细血管扩张是一种常见的美容疾病,可能与多种病症相关,如玫瑰痤疮。强脉冲光(IPL)疗法常用于治疗血管性病变。本研究测试了一种发射500 - 1200 nm范围内选定血管发色团特异性波长的IPL系统治疗血管性病变的疗效。
共纳入39例面部患有不同血管性病变的患者。治疗过程包括三个治疗疗程,间隔1个月,使用带有500 - 677 nm和854 - 1200 nm滤光片的IPL系统。在最后一次IPL疗程后21 - 90天(3周 - 3个月)进行随访。拍摄三维和皮肤镜临床照片,并采用五分制进行评估。检查不良事件。
总体而言,21例患者改善极佳,13例患者改善良好,3例患者改善中等,2例患者改善轻微,0例患者无改善,总体治疗反应良好。摄影评估显示,在最后一次IPL疗程后3天就取得了良好效果。未出现相关副作用。
该研究设备可能是一种成功的治疗方法,可改善对激光治疗耐药的血管性病变。